Chapter 56: management of STEMI Flashcards
what is a myocardial infraction
necrosis of the myocardium resulting form ischemia
what is STEMI
acute MI caused by complete interruption of regional myocardial blood flow
- causes ST segment elevation
Diagnosis of STEMI
- chest pain
- elevation of ST segment on ECG
- sweating, weakness, sense of impending doom
Biochemical markers for MI
- cardiac troponin I and cardiac troponin T
- MB isozyme of creatine kinase (CK-MB)
STEMI routine drug therapy
- oxygen
- acetylsalicylic acid
- morphine
- beta blockers: atenolol, metoprolol
- nitroglycerin
STEMI reperfusion therapy
- want to restore blood flow through the blocked coronary artery
- primary percutaneous coronary intervention (PCI) (angioplasty-stent)
- fibrinolytic (thrombolytic) therapy
Fibrinolytic (thrombolytic) therapy goal
to improve ventricular function, limit size of infract, and reduce mortality
Fibrinolytic (thrombolytic) therapy is most effects when
patient presents early; not given if pain has been present longer than 12 hours
- best if given during forst 4-6 hours
timely administration of fibrinolytic (thrombolytic) therapy =
opening of accluded artery in 80% of patients
what is the target time of fibrinolytic therapy
30 min target time
fibrinolytic therapy is best for patients younger than
75 years old
management of STEMI drugs
- unfractionated heprin
- low molecular weight heparin
- antiplatelet drugs
unfractionated heparin used for treatment
lasting less than 48 hours
low molecular weight heparin is used for treatment
loasting longer than 48 hours
antiplatelet drug examples
- clopidogrel [plavix]
- GP IIb/IIb inhibitors
- low dose acetylsalicylic acid (asprin)